Author(s): Frieri M
Abstract Share this page
Abstract OBJECTIVE: To review the complex interactions and processes in systemic lupus erythematosus (SLE). DATA SOURCES: Brief review of the important literature in peer-reviewed journals. STUDY SELECTION: Studies on the clinical and immunologic features, pathogenesis, epidemiology, laboratory evaluation, and treatment of SLE are included in this review. RESULTS: SLE may include a variety of disease entities, such as isolated cutaneous lupus, undifferentiated connective tissue disease, mixed connective tissue disease, and drug-induced lupus. There are many ongoing clinical trials in SLE patients of therapeutics with different mechanisms of cellular action, such as classic immunosuppression, cell depletion, antigen-specific immunomodulation, and targeting of antigen-nonspecific, immune-activating molecules. New immune cell-targeted therapies are now available that are specifically designed to block cellular pathways involved in disease pathogenesis. CONCLUSION: The practicing physician should understand the immunology, pathogenesis, laboratory evaluation, and updated treatment options when diagnosing SLE in their clinic or daily practice. Copyright © 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
This article was published in Ann Allergy Asthma Immunol
and referenced in Journal of Molecular Biomarkers & Diagnosis